A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

NCT06966284 · clinicaltrials.gov ↗

RECRUITING

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacteremia Caused by Gram-Negative Bacteria
Bacterial Pneumonia

Sponsor

TTY Biopharm